Again just words. Is this the management team to be able to deliver on this? Remember the directors didn't participate in the cap raising so they are not hurting like you shareholders who did.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025
OAR Chris Judd's Talk Ya Book: Orthocell building on 'enormous potential' with steady growth - and US push to come